Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017)
Crinetics Pharmaceuticals (CRNX) recorded quarterly Times Interest Earned of -$2501.0 in Q4 2017, down 110.7% quarter-over-quarter from -$1187.0 in Q3 2017.
Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017) Analysis & Trends
Crinetics Pharmaceuticals' Times Interest Earned history runs 1 years deep, the most recent figure standing at -$2501.0 for Q4 2017.
- In Q4 2017, Times Interest Earned changed N/A year-over-year to -$2501.0; the TTM figure through Sep 2018 stood at -$21780.0 (changed N/A YoY), while the FY2017 annual figure was -$1140.9, down 107.64% from the prior year.
- Times Interest Earned was -$2501.0 for Q4 2017 at Crinetics Pharmaceuticals, down from -$1187.0 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$547.67 in Q2 2017 to a low of -$2501.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Crinetics Pharmaceuticals | 3.49 Bn | 3.49 Bn | 10.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -2,501.00 |
| Sep 30, 2017 | -1,187.00 |
| Jun 30, 2017 | -547.67 |